Your session is about to expire
← Back to Search
Cannabis Abstinence for Depression
Study Summary
This trial investigates the effects of cannabis abstinence over a 28-day period in patients with MDD with co-occurring CUD using a randomized controlled design, namely contingent reinforcement.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2011 Phase 2 trial • 250 Patients • NCT00685178Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been on a stable dose of antidepressants for at least three months.I am between 18 and 55 years old.I had a head injury that made me unconscious for over 5 minutes.
- Group 1: Non-Contingency Reinforcement Group
- Group 2: Contingency Reinforcement Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who has the aptitude to join this investigation?
"To qualify for this trial, participants must have a history of hashish consumption and be within the ages 18-55. This research is looking to enroll 52 individuals in total."
Are there any vacancies available for individuals to participate in this clinical trial?
"According to clinicaltrials.gov, this trial commencing on July 21st 2021 is actively seeking participants. The most recent update was posted March 7th 2022."
How extensive is the participation in this trial?
"Confirmed. According to clinicaltrials.gov, the study is open for recruitment and was initially posted on July 21st 2021. Further updates were made in March 7th 2022, with 52 participants being targeted at one site."
What aims are this inquiry attempting to attain?
"The primary purpose of this research is to measure changes in anhedonia from the start of the trial, over a four-week period. Secondary objectives involve evaluating alterations in attention and visual search using Trail Making Test; sustained attention with Continuous Performance Tests and working memory Digit Span tests."
Does the criteria for this research encompass elderly participants?
"This trial has stipulated that potential participants should be between the age of 18 and 55. There are 130 studies available for those under 18, while 768 trials exist for senior citizens aged 65 or older."
Share this study with friends
Copy Link
Messenger